Continuous anti-IL-10 antibody administration prevents alymphoplasia mice from autoimmune exocrinopathy.
スポンサーリンク
概要
- 論文の詳細を見る
Aly (alymphoplasia) /aly mutant (ALY) mice were established as an animal model for immunodeficiency bearing an autosomal recessive gene with lack of lymph nodes and immunoglobulin especially IgA. Recently, Tsubata reported ALY mice exhibited autoimmune multiple exocrinopathy that strikingly resembles human Sjoegren's syndrome. Since the ALY mice lack conventional B cells, they had relatively abundant CD5<SUP>+</SUP>B cells producing IL-10 constitutively in lymphoid organs. IL-10 is a soluble protein produced by helper T (Th) cells, macrophages (Mφ), and B cells, that exhibits a wide array of both immunosuppressive and immunostimulatory properites.<BR>In order to explore the pathological significance of IL-10 in autoimmune exocrinopathy, ALY mice were administrated either anti-IL-10 or isotype control antibody continuously from 8 to 24 weeks. At 24 weeks, we sacrificed them and subjected the exocrine organs to pathological examinations.<BR>Inflammatory changes in lacrimal and salivary glands were significantly reduced by anti-IL-10 antibody treatment in ALY mutant mice. These results suggest that IL-10 might be involve the pathophysiology in multiple autoimmune exocrinopathy in ALY mutant mice.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発